Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention

Journal of Invasive Cardiology

Volumn 22, Issue 7, 2010, Pages 307-311

  Savic, Lidija ^a   Mrdovic, Igor ^a,c   Perunicic, Jovan ^a,c   Asanin, Milika ^a,c   Lasica, Ratko ^a   Marinkovic, Jelena ^c,d   Vasiljevic, Zorana ^a,c   Ostojic, Miodrag ^b,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Institute of Medical Statistics and Informatics   (Serbia)

Author keywords

acute ST elevation myocardial infarction; heart failure; primary percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATINE KINASE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; TIROFIBAN;

ACUTE HEART FAILURE; ADULT; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE DISEASE; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; INPATIENTS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SURVIVAL RATE;

EID: 77957095979     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Santoro GM, Carraba N, Migliorini A, et al. Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Heart Fall 2008;10:780-785.
2. Van der Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The task Force of the management of ST-elevation acute myocardial infarction of the European Society of Cardiology. Eur Hear J 2008;29:2909-2945.
3. Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure. The National Registry of Myocardial Infarction. Circulation 2002;105:2605-2610.
4. Velazquez EJ, Pefffer MA. Acute heart failure complicating acute coronary syndromes. A deadly intersection. Circulation 2004;109:440-442.
5. Flaherty JD, Bax JJ, De Luca L, et al. Acute heart failure syndromes in patients with coronary artery disease. Early assessment and treatment. J Am Coll Cardiol 2009;53:254-263.
6. Steg PG, Dabbous OH, Feldman LJ, et al. FA. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-499.
7. DeGeare VS, Boura JA, Grines LL, et al. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001;87:1035-1038.
8. Mrdovic I, Savic L, Perunicic J, et al. Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel. Rationale and design of the RISK-PCI study. J Intervent Cardiol 2009;22:320-328.
9. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004. Guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007;116;816-877.
10. Hellermann JP, Jacobsen SJ, Gersh BJ, et al. Heart failure after myocardial infarction: A review. Am J Med 2002;113:342-1330
11. Jhund PS, McMurray JJV. Heart failure after myocardial infarction. A lost battle in the war on heart failure. Circulation 2008;118:2019-2021.
12. Hamdan A, Kornowski R, Solodky A, et al. Predictors of left ventricular dysfunction in patients with first acute anterior myocardial infarction undergoing primary angioplasty. IMAJ 2006;8:532-535.
13. Wu AH, Parsons L, Every NR, Bates ER. Hospital outocomes in patients presenting with congestive heart failure complicating acute myocardila infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002;40:1389-1394.
14. Wu CJ, Chang HW, Hung WC, et al. N-terminal pro-brain natriuretic pepetide is a biomarker of congestive heart failure and predicitve of 30-day untoward clinical outcomes in percutaneous coronary intervention. Circ J 2006;70:163-168.
15. Stone PH, Raabe DS, Jaffe AS, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988;11:453-463.
16. Hasdai D, Topol EJ, KIlaru R, et al. Frequency, patient characterisctics and outcome of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction:lesson from 4 international fibrinolytic therapy trials. Am Heart J 2003:145:73-79.
17. De Luca G, van't Hof AWJ, de Boer MJ, et al. Impaired myocardial perfusion is major explanation of poor outcome observed in patients undergoing primary angioplasty fo ST-segment-elevation myocardial infarction and signs of heart failure. Circulation 2004;109:958-961.
18. Kashani A, Giugliano RP, Antman EM, et al. Severity of heart failure treatments, and outcome after fibrinolysis in patients with ST-elevation myocardial infarction. Eur Hear J 2004;25:1702-1710.